Rankings
▼
Calendar
ARGX Q2 2019 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena
ARGX
argenx SE
$45B
Q2 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$51M
+150.3% YoY
Gross Profit
-$27M
-52.6% margin
Operating Income
-$54M
-106.2% margin
Net Income
-$45M
-88.0% margin
EPS (Diluted)
$-1.19
Cash Flow
Operating Cash Flow
$228M
Free Cash Flow
$228M
Stock-Based Comp.
$17M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$51M
$20M
+150.3%
Gross Profit
-$27M
-$14M
-94.7%
Operating Income
-$54M
-$25M
-114.5%
Net Income
-$45M
-$20M
-124.8%
Geographic Segments
L
$27M
63%
C
$15M
36%
D
$128,000
0%
← Q4 2018
All Quarters
Q4 2019 →